Search Results - "Salpeter, Shelley R"

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta-analysis and Systematic Review by Salpeter, Shelley R., MD, Buckley, Jacob S, Chatterjee, Saurav, MD

“…Abstract Background There is accumulating evidence that restricting blood transfusions improves outcomes, with newer trials showing greater benefit from more…”
Get full text

Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women by Salpeter, Shelley R., MD, Cheng, Ji, MSc, Thabane, Lehana, PhD, Buckley, Nicholas S, Salpeter, Edwin E., PhD (Posthumous)

“…Abstract Background There is uncertainty over the risks and benefits of hormone therapy. We performed a Bayesian meta-analysis to evaluate the effect of…”
Get full text

Meta-analysis: Metformin Treatment in Persons at Risk for Diabetes Mellitus by Salpeter, Shelley R., MD, Buckley, Nicholas S, Kahn, Justin A, Salpeter, Edwin E., PhD

“…Abstract Purpose We performed a meta-analysis of randomized controlled trials to assess the effect of metformin on metabolic parameters and the incidence of…”
Get full text

Cardioselective beta-blockers for chronic obstructive pulmonary disease by Salpeter, S, Ormiston, T, Salpeter, E

“…Beta-blocker therapy has a proven mortality benefit in patients with hypertension, heart failure and coronary artery disease, as well as during the…”
Get more information

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis by Kielstein, Jan T., Salpeter, Shelley R., Bode-Boeger, Stefanie M., Cooke, John P., Fliser, Danilo

“…Background. Dosing of most drugs must be adapted in renal insufficiency, making accurate assessment of renal function essential in clinical medicine…”
Get full text

Systematic Review : The Effects of Growth Hormone on Athletic Performance by HAU LIU, BRAVATA, Dena M, HOFFMAN, Andrew R, OLKIN, Ingram, FRIEDLANDER, Anne, LIU, Vincent, ROBERTS, Brian, BENDAVID, Eran, SAYNINA, Olga, SALPETER, Shelley R, GARBER, Alan M

“…Human growth hormone is reportedly used to enhance athletic performance, although its safety and efficacy for this purpose are poorly understood. To evaluate…”
Get full text

Long-acting Beta-Agonists with and without Inhaled Corticosteroids and Catastrophic Asthma Events by Salpeter, Shelley R., MD, FACP, Wall, Andrew J., MD, Buckley, Nicholas S

“…Abstract Background It is unclear whether long-acting β-agonists with concomitant inhaled corticosteroids increase asthma-related intubations and deaths. We…”
Get full text

Systematic Review of Noncancer Presentations with a Median Survival of 6 Months or Less by Salpeter, Shelley R., MD, Luo, Esther J., MD, Malter, Dawn S., MD, PhD, Stuart, Brad, MD

“…Abstract Purpose We report on clinical indicators of 6-month mortality in advanced noncancer illnesses and the effect of treatment on survival. Methods The…”
Get full text

The Cost-effectiveness of Hormone Therapy in Younger and Older Postmenopausal Women by Salpeter, Shelley R., MD, Buckley, Nicholas S, Liu, Hau, MD, MBA, Salpeter, Edwin E., PhD

“…Abstract Purpose To evaluate the health and economic outcomes of hormone therapy in younger and older postmenopausal women. Methods We developed a…”
Get full text

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus by Salpeter, Shelley R, Greyber, Elizabeth, Pasternak, Gary A, Salpeter, Edwin E

“…Metformin is an oral anti-hyperglycemic agent that has been shown to reduce total mortality compared to other anti-hyperglycemic agents, in the treatment of…”
Get more information

A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence by Buckley, Jacob S., Salpeter, Shelley R.

“…Background There is no cure for dementia, and no treatments exist to halt or reverse the course of the disease. Treatments are aimed at improving cognitive and…”
Get full text

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus by Salpeter, Shelley R, Greyber, Elizabeth, Pasternak, Gary A, Salpeter Posthumous, Edwin E

“…Metformin is an oral anti-hyperglycemic agent that has been shown to reduce total mortality compared to other anti-hyperglycemic agents, in the treatment of…”
Get more information

Meta-analysis : Effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths by SALPETER, Shelley R, BUCKLEY, Nicholas S, ORMISTON, Thomas M, SALPETER, Edwin E, GLASSROTH, Jeffrey

“…Long-acting beta-agonists may increase the risk for fatal and nonfatal asthma exacerbations. To assess the risk for severe, life-threatening, or fatal asthma…”
Get full text

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis by Salpeter, Shelley R, Ormiston, Thomas M, Salpeter, Edwin E

“…beta-Adrenergic agonists exert physiologic effects that are the opposite of those of beta-blockers. beta-Blockers are known to reduce morbidity and mortality…”
Get more information

Do Inhaled Anticholinergics Increase or Decrease the Risk of Major Cardiovascular Events?: A Synthesis of the Available Evidence by Salpeter, Shelley R.

“…There has been recent uncertainty about whether the inhaled anticholinergic agents ipratropium bromide and tiotropium bromide increase or decrease…”
Get full text

BRIEF REPORT: Coronary Heart Disease Events Associated with Hormone Therapy in Younger and Older Women by Salpeter, Shelley R., Walsh, Judith M. E., Greyber, Elizabeth, Salpeter, Edwin E.

“…OBJECTIVE: To assess the effect of hormone therapy (HT) on coronary heart disease (CHD) events in younger and older postmenopausal women. DESIGN: A…”
Get full text

Gene Expression Profiles as Predictors of Poor Outcomes in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis by Lu, An-Ting T, Salpeter, Shelley R, Reeve, Anthony E, Eschrich, Steven, Johnston, Patrick G, Barrier, Alain J, Bertucci, Francois, Buckley, Nicholas S, Salpeter, Edwin E, Lin, Albert Y

“…Abstract Purpose The use of adjuvant therapy in stage II colorectal cancer (CRC) remains controversial. There is a need to identify more effective predictors…”
Get full text

The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia by Salpeter, Shelley R, Buckley, Jacob S, Bruera, Eduardo

“…Opioid dose escalation may cause hyperalgesia, mediated by the N-methyl-D-aspartate (NMDA) pathway. Methadone is an atypical opioid that inhibits hyperalgesia…”
Get more information

Cardioselective β-blockers in patients with reactive airway disease: A meta-analysis by SALPETER, Shelley R, ORMISTON, Thomas M, SALPETER, Edwin E

“…To assess the effect of cardioselective beta-blockers on respiratory function of patients with reactive airway disease. Comprehensive searches of the EMBASE,…”
Get full text

The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report by Salpeter, Shelley R, Buckley, Jacob S, Buckley, Nicholas S, Bruera, Eduardo

“…Our aim was to evaluate the use of very-low-dose methadone with haloperidol in the acute-care setting. We reviewed the records of 735 hospitalized patients…”
Get more information